BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Cell Therapy
    • COVID-19
    • CAR-T
    • Cord Blood
  • Exosomes
  • Interviews
  • News
    • Press Releases
    • Job Posts
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Stem Cells » MSCs » Page 57

Mesenchymal Stem Cells (MSCs)

Mesenchymal stem cells (MSCs) are a well-characterized population of adult stem cells that can differentiate into a variety of cell types (chondrocytes, osteoblasts, adipocytes, myocytes, and more).

(My Story) President of a Stem Cell Market Research Firm and a Stem Cell Patient

March 12, 2015 By Cade Hildreth (CEO) 1 Comment

Cade Hildreth, Autologous Stem Cell Patient

For the past 15 years, I have studied stem cells, including technology and research advances, as well as market trends. I have been fascinated with them for most of my adult life, founding BioInformant as the first and only market research firm to specialize in the stem cell industry.

As a result of this decision, I have had the honor of serving thousands clients from across the stem cell industry and been interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine.

However, it was only recently that I experienced the power of stem cells to impact my own life and health.

[Read more…]

Filed Under: MSCs, Stem Cells Tagged With: autologous, cell therapy, regenerative medicine, stem cells

“Cord Blood” Reaches Nearly $40 Per Click in the U.S. and More Than $20 Per Click Worldwide

February 18, 2015 By Cade Hildreth (CEO) 1 Comment

Cord Blood Reaches One of the 20 Most Expensive Search Terms on Google

Because Google controls over 70% of online searches, it is an incredible resource for analyzing online search behavior. Recently, the search term “Cord Blood” became one of the 20 most expensive keywords on Google Adwords,[1] an incredible finding given the variety and total volume of searches that occur through Google.

Individuals or companies who buy the exact search phrase “Cord Blood” through Google AdWords now pay $38.38[2] to win search traffic for this phrase within the United States. [Read more…]

Filed Under: Cord Blood, HSCs, MSCs Tagged With: cord blood, cord blood market, google adwords, hematopoietic stem cells, industry trends, market research, mesenchymal stem cells

What Percentage of U.S. Parents Store Cord Blood Publicly and Privately?

February 8, 2015 By Cade Hildreth (CEO) Leave a Comment

Global Cord Blood Banking Market

The cord blood banking industry has grown increasingly complex over the past few years. While rates of growth within the industry were robust during the early 2000’s, it is no longer the rapid growth market that it used to be. There is now increased market competition, tighter regulatory standards, more substantial government oversight, and increased public scrutiny given toward cord blood industry practices.
[Read more…]

Filed Under: Cord Blood, HSCs, MSCs, Stem Cells Tagged With: birth rate, CorCell, cord blood, Cord Blood America, Cord Blood Registry, Cryo-Cell, hematopoietic stem cells, market research, market size, ViaCell

  • « Previous Page
  • 1
  • …
  • 55
  • 56
  • 57

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Cell Therapy Manufacturing Survey - Selection Criteria for Choosing a CMO Partner
    Rated 0 out of 5
    $197 $97
  • Stem Cell Fact Sheet - Types of Stem Cells and their Use in Medicine
    Rated 0 out of 5
    $10
  • Global Database of Research Supply Companies Global Database of Research Supply Companies 2021
    Rated 0 out of 5
    $39

Featured Posts

Vitro Biopharma

Vitro Biopharma Receives FDA Authorization to Conduct a Clinical Trial Using AlloRx Stem Cells® to Treat COVID-19

CAR-T Companies

CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide

MSC market

How the MSC Market is Coming of Age in 2021

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2021 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.